$ABOS
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.
Healthcare
Sector
Biotechnology
Industry
Daniel J. O'Connell
CEO
61
Employees
$2.92
Current Price
$164.76M
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 2 weeks | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 1 month | Buys | 0 | 0 | - | - | All Sells |
| Sells | 1 | 2 | $35,124.52 | 11,496 | ||
| 2 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 5 | 10 | $111,743.94 | 41,672 | ||
| 3 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 7 | 44 | $535,918.79 | 266,428 | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
Showing 21โ40 of 44 transactions
Upcoming Earnings
Scheduled earnings reports
EPS
Estimated-$0.45
ActualN/A
Revenue
EstimatedN/A
ActualN/A
EPS
Estimated-$0.45
ActualN/A
Revenue
EstimatedN/A
ActualN/A
EPS
EstimatedN/A
ActualN/A
Revenue
EstimatedN/A
ActualN/A
Past Earnings
Historical earnings results
No earnings data in the last 3 months. Sign up free to see 12 months of history.